POS0788 BIMEKIZUMAB DEMONSTRATED SUSTAINED EFFICACY AND SAFETY ACROSS THE FULL SPECTRUM OF AXIAL SPONDYLOARTHRITIS: 3-YEAR RESULTS FROM TWO PHASE 3 STUDIES AND THEIR OPEN-LABEL EXTENSION.
X. Baraliakos, A. Deodhar, D. van der Heijde, F. van den Bosch, M. Magrey, W.P. Maksymowych, T. Tomita, H. Xu, D. Voiniciuc, C. Prajapati, M. Manente, A. Marten, L.S. Gensler
